Principal Investigator(s):Myron Essex, Victor DeGruttola, Refeletswe Lebelonyane & Shanaaz El Halabi
Objective:Designed to test the hypothesis that implementing an enhanced combination prevention package which includes provision of ART as prevention for HIV-infected individuals will impact the HIV/AIDS epidemic by significantly reducing population-level, cumulative HIV incidence in a defined geographic area over a period of 3 years and will be cost-effective.Last updated September 8, 2022
Start Date
End Date
October 31, 2013
July 23, 2018
Age range: 16 Years ↔ 64 Years
Population:Cisgender Men, Cisgender Women, People Living with HIV